SCHEMBL25856127

SCHEMBL25856127

CN1CC(CN2CCCC3(CCNCC3)C2)C1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 13/20 0.47
CYP3A4 P08684 10/20 0.45
ALDH1A1 P00352 8/20 0.45
CYP2C19 P33261 7/20 0.45
TSHR P16473 7/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP2C9 P11712 5/20 0.42
TP53 P04637 4/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
USP2 O75604 5/20 0.40
CYP1A2 P05177 6/20 0.39
HSD17B10 Q99714 4/20 0.39
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
ALOX15 P16050 1/20 0.35
KDM1A O60341 1/20 0.34
MAOB P27338 1/20 0.34
RCOR1 Q9UKL0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24480569 0.86 OPRM1 (0.34) CYP2D6CYP3A4ALDH1A1CYP2C19TSHR
Hydrochloric Acid SCHEMBL21073999 0.83 CYP2D6 (0.50) CYP2D6CYP3A4ALDH1A1CYP2C19TSHR
SCHEMBL29317112 0.83 CYP2D6 (0.50) CYP2D6CYP3A4ALDH1A1CYP2C19TSHR
SCHEMBL22564911 0.77 OPRM1 (0.36) TSHR
SCHEMBL22564921 0.77 TSHR (0.44) CYP2D6CYP3A4ALDH1A1CYP2C19TSHR
SCHEMBL24480559 0.77 OPRM1 (0.36) CYP2D6CYP3A4CYP2C19TSHRCYP2C9
Hydrochloric Acid SCHEMBL31097575 0.77 CYP2D6 (0.45) CYP2D6CYP3A4ALDH1A1CYP2C19TSHR
SCHEMBL24481345 0.76 OPRM1 (0.33) CYP2D6CYP3A4CYP2C19TSHRCYP2C9
SCHEMBL25026759 0.75 CYP2D6 (0.35) CYP2D6CYP3A4ALDH1A1CYP2C19TSHR
SCHEMBL20353639 0.75 TSHR (0.61) CYP2D6CYP3A4ALDH1A1CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO disclosed